The mission of the urology research group, part of NYU Long Island School of Medicine’s Department of Urology, is to investigate clinical outcomes for patients with a full range of urologic conditions, including cancers, to improve both our understanding of these conditions and overall quality of life. Our research team works closely with attending physicians, residents, statisticians, and other research staff at NYU Langone Hospital—Long Island on industry-sponsored clinical trials and investigator-initiated research projects.
Since its inception in 2013, the urology research group has developed several research databases for prostate and bladder cancer, as well as minimally invasive treatments for benign prostatic hyperplasia. Our goal is to initiate more clinical projects and several research databases focusing on areas such as disease detection and treatment, as well as prediction of clinical and quality-of-life outcomes for patients with prostate cancer. We are also becoming more involved in nationally recognized databases, such as the National Cancer Database.
Group members frequently publish their research and present abstracts at regional, national, and international meetings, and also actively participate in the department’s Summer Urology Research Program serving as mentors for participating medical students.